Clinical trial

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

NCT05452005

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention [18F]-αvβ6-BP Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-09-13

PhasePHASE1

Conditions

Lung Cancerverified · MONDO: lung cancer

Lung Cancer Metastaticunresolved

Brain Metastasesunresolved

Non Small Cell Lung Cancercandidate · MONDO: non-small cell lung carcinoma

Interventions

[18F]-αvβ6-BPDRUG

Sponsors & collaborators

University of California, Davislead sponsor

United States Department of Defensecollaborator

Mapped research locations

SacramentoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05452005 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.